non-physiological amino acid (npaa) therapy in pah enu2 mice relevance to pku therapy
DESCRIPTION
Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy. Mike Gibson, Professor and Head Section of Clinical Pharmacology Washington State University (WSU) Spokane College of Pharmacy, Spokane WA . Disclosures: None. Rationale and Goals. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/1.jpg)
Non-Physiological Amino Acid (NPAA) Therapy in Pahenu2 Mice
Relevance to PKU Therapy
Mike Gibson, Professor and HeadSection of Clinical Pharmacology
Washington State University (WSU) SpokaneCollege of Pharmacy, Spokane WA
Disclosures: None
![Page 2: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/2.jpg)
Rationale and Goals
• To Selectively Lower Brain Phenylalanine – NPAAs targeting L and A systems (BBB and gut)– Maintain Other LNAAs at or Near Normal Levels
• Adjuvant Therapy, Target Cognitive Improvements
Mammalian System L Transporters Specific for LNAAsTransporter Expression Amino AcidsTransported LAT-1 Li (fetal), BM, Br, Pl, Te L-I-V-F-Y-W-M-H LAT-2 Je, Ile, Ki, Pl, Br, Te, Sp L-F-W-T-N-I-C-S-Y-V-Q LAT-3 Pa, Li (fetal, adult), SM L-I-V-F LAT-4 Pl, Ki, Leuc L-F-I-M
![Page 3: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/3.jpg)
Non-Physiological Amino Acids
A=Norleucine B=2-Aminoisobutyrate C=N-Methyl-2-aminoisobutyrate D=2-aminonorbornane-2-carboxylic acid
Only NL previously usedin a mammalian system
Km values of LNAAs for LAT(s) may lead to NPAA concentrations that selectively lower Phe while minimally altering other LNAAs
![Page 4: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/4.jpg)
Brain Amino Acid Transport Systems
• ~ Amino Acid Specificity• Considerable Overlap• Glutamine (Q): Numerous• Na
Dependent/Independent• A ~ Smaller Amino Acids• L ~ Larger Amino Acids
![Page 5: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/5.jpg)
Approach
• Dietary Administration-Clinical Relevance• Control Nitrogen Load with Casein• Monitor Brain LNAAs and Monoamines– Monitor Behavior/Movement in Future
• Blood Chemistries (Safety)– Assess Effects on Nitrogen Load
• Develop Methods to Quantify NPAAs
![Page 6: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/6.jpg)
LNAA Metabolic Roles
![Page 7: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/7.jpg)
Pilot Studies-Effect on Phe/TyrPhenylalanine Tyrosine
![Page 8: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/8.jpg)
Results for Monoamines
Serotonin Dopamine
![Page 9: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/9.jpg)
Additional LNAA Outcomes
Tryptophan Total Branched Chain AAs
![Page 10: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/10.jpg)
Effects on 1-Methyl Transfer
Methionine SAMe
![Page 11: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/11.jpg)
Conclusions
• Proof-of-Principle: Feasibility– Phe Reduction with NL, NB and MAIB– Other LNAA Effects: Lower Levels of NL and NB– Movement Effects of 3-5% NL Prominent– First Use of These in an Murine PKU Model
• MAIB is a Selective A System Inhibitor– Can Clearly Reduce Phe, However– Not Previously Documented– More Benign Effects than 5% NL, 0.5% NB
![Page 12: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/12.jpg)
Goals in Future Studies
• Different Concentrations of NPAAs• Combinatorial Administration (BBB-Gut)• NPAA Characterization in High/Low Protein• Address Variability in Some LNAA Levels• Evaluate Method of Sacrifice• Characterize Behavior during NPAA
Intervention
![Page 13: Non-Physiological Amino Acid (NPAA) Therapy in Pah enu2 Mice Relevance to PKU Therapy](https://reader035.vdocuments.us/reader035/viewer/2022070423/56816685550346895dda2e25/html5/thumbnails/13.jpg)
AcknowledgementsColleagues/Funding
• Alliance Support• Kara Vogel• Brandi Wasek• Erland Arning• Terry Bottiglieri• R01 HD 58553• U54 DK 83916